France Hereditary Cancer Testing Market to 2032
Overview
The France Hereditary Cancer Testing Market is expected to reach a 625.33 USD Million by 2032 and is projected to grow at a CAGR of 20.30% from 2025 to 2032.
Revenue, 2024 (USD Million)
239.29
Forecast, 2032 (USD Million)
625.33
CAGR, 2024 - 2032
20.30%
Report Coverage
France
France Hereditary Cancer Testing Market 2018-2032 USD Million
France Hereditary Cancer Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 239.29 USD Million
- Projected Market Size (2032): 625.33 USD Million
- CAGR (2025-2032): 20.30%
Key Findings of France Hereditary Cancer Testing Market
- The France Hereditary Cancer Testing Market was valued at 239.29 USD Million in 2024.
- The France Hereditary Cancer Testing Market is likely to grow at a CAGR of 20.30% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 161.87 USD Million
- The fastest growing segment Hospitals in End Users Segment grew Fastest with a CAGR of 21.23% during the forecast period from 2024 to 2032.
France Hereditary Cancer Testing Market Scope
France Hereditary Cancer Testing Market Segmentation & Scope
Disease
- Multiple Endocrine Neoplasias (MEN) Syndrome
- Von Hippel-Lindau Disease
- Li-Fraumeni Syndrome
- Familial Adenomatous Polyposis (FAP)
- Hereditary Leukemia and Hematologic Malignancies Syndrome
- Lynch Syndrome
- Cowden Syndrome
- Hereditary Breast & Ovarian Cancer Syndrome
Technology
- Microarray
- Sequencing
- Polymerase Chain Reaction (PCR)
Diagnosis
- Lab Tests
- Imagining
- Biopsy
Distribution Channel
- Retail Sales
- Direct Tender
End Users
- Others
- Laboratories
- Radiology Centres
- Diagnostics Centers
- Clinics
- Hospitals
Test
- Single Site Genetic Test
- Multi Panel Test
France Hereditary Cancer Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 239.29 USD Million |
| Market Value in 2032 | 625.33 USD Million |
| CAGR (2025-2032) | 20.30% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Disease,Technology,Diagnosis,Distribution Channel,End Users,Test |
Regional Insights:
-
Leading Market (2024-2032): France, leading in terms of revenue 239.29 USD Million in 2024
- Key Country: France, leading in terms of revenue with value of 239.29 USD Million in 2024.
Segments and Scope
-
France Hereditary Cancer Testing Market to 2032, By Disease
- Hereditary Breast & Ovarian Cancer Syndrome is the largest segment in France Hereditary Cancer Testing Market to 2032 with a revenue of 137.18 USD Million in the year 2024.
- Hereditary Breast & Ovarian Cancer Syndrome is the Fastest growing segment in France Hereditary Cancer Testing Market to 2032 with a Growth rate of 20.94 % in forecast period 2025-2032.
-
France Hereditary Cancer Testing Market to 2032, By Technology
- Polymerase Chain Reaction (PCR) is the largest segment in France Hereditary Cancer Testing Market to 2032 with a revenue of 153.54 USD Million in the year 2024.
- Polymerase Chain Reaction (PCR) is the Fastest growing segment in France Hereditary Cancer Testing Market to 2032 with a Growth rate of 20.79 % in forecast period 2025-2032.
-
France Hereditary Cancer Testing Market to 2032, By Diagnosis
- Biopsy is the largest segment in France Hereditary Cancer Testing Market to 2032 with a revenue of 102.08 USD Million in the year 2024.
- Biopsy is the Fastest growing segment in France Hereditary Cancer Testing Market to 2032 with a Growth rate of 20.67 % in forecast period 2025-2032.
-
France Hereditary Cancer Testing Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in France Hereditary Cancer Testing Market to 2032 with a revenue of 161.87 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in France Hereditary Cancer Testing Market to 2032 with a Growth rate of 20.48 % in forecast period 2025-2032.
-
France Hereditary Cancer Testing Market to 2032, By End Users
- Hospitals is the largest segment in France Hereditary Cancer Testing Market to 2032 with a revenue of 88.03 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in France Hereditary Cancer Testing Market to 2032 with a Growth rate of 21.23 % in forecast period 2025-2032.
-
France Hereditary Cancer Testing Market to 2032, By Test
- Multi Panel Test is the largest segment in France Hereditary Cancer Testing Market to 2032 with a revenue of 156.19 USD Million in the year 2024.
- Multi Panel Test is the Fastest growing segment in France Hereditary Cancer Testing Market to 2032 with a Growth rate of 20.70 % in forecast period 2025-2032.
France Hereditary Cancer Testing Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| illumina, inc. | |||
| Abbott | |||
| Eurofins Scientific | |||
| LifeLabs Genetics | |||
France Hereditary Cancer Testing Market Geographical Sales Distribution, 2018-2032 USD Million
France Hereditary Cancer Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The France Hereditary Cancer Testing Market is segmented based on Segmentation Disease,Technology,Diagnosis,Distribution Channel,End Users,Test.
France Hereditary Cancer Testing Market was valued at USD 239.29(Revenue in USD Million) in 2020.
France Hereditary Cancer Testing Market is projected to grow at a CAGR of 20.30% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the France Hereditary Cancer Testing Market, holding a largest market share of 161.87 USD Million in 2024
France Hereditary Cancer Testing Market Scope
France Hereditary Cancer Testing Market Segmentation & Scope
Disease
- Multiple Endocrine Neoplasias (MEN) Syndrome
- Von Hippel-Lindau Disease
- Li-Fraumeni Syndrome
- Familial Adenomatous Polyposis (FAP)
- Hereditary Leukemia and Hematologic Malignancies Syndrome
- Lynch Syndrome
- Cowden Syndrome
- Hereditary Breast & Ovarian Cancer Syndrome
Technology
- Microarray
- Sequencing
- Polymerase Chain Reaction (PCR)
Diagnosis
- Lab Tests
- Imagining
- Biopsy
Distribution Channel
- Retail Sales
- Direct Tender
End Users
- Others
- Laboratories
- Radiology Centres
- Diagnostics Centers
- Clinics
- Hospitals
Test
- Single Site Genetic Test
- Multi Panel Test
Frequently Asked Questions
The France Hereditary Cancer Testing Market is segmented based on Segmentation Disease,Technology,Diagnosis,Distribution Channel,End Users,Test.
France Hereditary Cancer Testing Market was valued at USD 239.29(Revenue in USD Million) in 2020.
France Hereditary Cancer Testing Market is projected to grow at a CAGR of 20.30% during the forecast period of 2024 to 2032.
The estimated market value of the France Hereditary Cancer Testing Market for final year is USD 625.33 (USD Million).
France Hereditary Cancer Testing Market Company Profiling
Frequently Asked Questions
The France Hereditary Cancer Testing Market is segmented based on Segmentation Disease,Technology,Diagnosis,Distribution Channel,End Users,Test.
France Hereditary Cancer Testing Market was valued at USD 239.29(Revenue in USD Million) in 2020.
France Hereditary Cancer Testing Market is projected to grow at a CAGR of 20.30% during the forecast period of 2024 to 2032.
The estimated market value of the France Hereditary Cancer Testing Market for final year is USD 625.33 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.